№ files_lp_4_process_3_128704
File format: docx Character count: 20800 File size: 47 KB
This document is a research study analyzing the association between antidepressant use and cardiovascular disease risk, based on data from the Atherosclerosis Risk in Communities (ARIC) study.
Year: 2016
Region / City: United States
Topic: Cardiovascular risk, antidepressants
Document Type: Research study
Institution: ARIC Study
Author: Zakaria Almuwaqqat
Target Audience: Researchers, Healthcare Professionals
Period of Activity: 2016
Approval Date: 2016
Date of Last Modification: 2016
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Atherosclerosis and FXR1 Gene Regulation by IL-19
Year: 2023
Region / City: Laboratory / Research Setting
Topic: Atherosclerosis, FXR1 Protein, IL-19, Gene Expression
Document Type: Research Report
Institution: Unspecified Research Institution
Author: Unspecified Researcher
Target Audience: Researchers in Genetics and Molecular Biology
Period of Activity: Ongoing
Date of Approval: Unspecified
Date of Changes: Unspecified
ARIC Dataset Request for Approved Manuscripts and Ancillary Studies
Year: 2023
Region / city: United States
Topic: Epidemiology, Data Access
Document type: Data Request Form
Author: ARIC Study Team
Target audience: Researchers, Data Requestors
Period of validity: Not specified
Approval date: Not specified
Date of modifications: Not specified
The Practice of Health – Antidepressant Review Form
Organisation: The Practice of Health
Document Type: Medical review form
Subject: Antidepressant medication review
Related Institution: NHS
Note: Related Institution Royal College of Psychiatrists
Purpose: Assessment of ongoing antidepressant treatment
Target Audience: Patients prescribed antidepressant medication
Data Collected: Name, date of birth, telephone number, email, medical information
Review Criteria: Mood stability, medication benefit, intrusive thoughts, side effects
Treatment Guidance Period: 6 months to 2 years depending on risk and indication
Consent Requirement: Patient consent for data collection and storage
Privacy Reference: Practice Privacy Policy
Clinical Contact Options: GP, Pharmacist, Duty Doctor
Optimizing Antidepressant Selection through Artificial Intelligence
Year: 2025
Region / City: Virginia
Theme: Artificial Intelligence in Healthcare
Document Type: Research Grant Summary
Organization: Robert Wood Johnson Foundation
Author: Farrokh Alemi, Ph.D.
Target Audience: Researchers, Healthcare Professionals
Period of Activity: 2024 - 2028
Approval Date: 2025
Modification Date: 2025
Project Outcome: The project developed an AI-based tool for antidepressant selection, used by over 1,500 patients.
Leveraged Funding: $1,120,904
Funding Agency: NIH’s Aim Ahead
Project Dates: 2024-2028
Amount Awarded: $1,049,998
Publications: Alemi F, Wojtusiak J, Ursani A, Eklou KP, Lybarger K. "Artificial Intelligence for Management of Major Depression: Initial Design, Progress, and Research Plans," Alpha Psychiatry, 2025
Contextual Description: Research summary on AI tools for optimizing antidepressant prescriptions and their clinical application.
Mood disorders in pediatric and adult patients: management of antidepressant therapy across the lifespan
Year: 2023
Region / City: Not specified
Topic: Mood disorders, ADHD, antidepressant therapy, medication management
Document Type: Educational material
Organization / Institution: Not specified
Author: Not specified
Target Audience: Medical students, healthcare professionals
Period of Effect: Ongoing
Approval Date: Not specified
Date of Changes: Not specified
The role of GABAergic interneuron subtypes in the antidepressant effects of Lily Bulb and Rehmannia Decoction (LBRD)
Year: 2026
Region / City: Jinan, Shandong; Beijing, China
Topic: Pharmacology, Traditional Chinese Medicine, Neuroscience
Document Type: Research article
Institution: Shandong University of Traditional Chinese Medicine; Chinese Academy of Traditional Chinese Medicine
Authors: Xiaoyan Xue, Hongxiu Zhang, Yanting Lu, Jin Pan, Qiancheng Mao, Xing Chang, Shijun Wang, Xiaobin Song, Ke Ma
Correspondence: Shijun Wang, Xiaobin Song, Ke Ma
Methods: UHPLC-Q-TOF/MS, HPLC, UPLC-QTOF-MS/MS
Subject: GABAergic interneurons, antidepressant activity, LBRD formulation
Supplementary Figures: Total ion chromatogram, HPLC chromatograms, PV and VIP interneuron effects
Supplementary Tables: Chemical constituents characterization, quality control data
Context: Experimental study detailing chemical composition of LBRD and its effects on GABAergic interneuron subtypes in a research setting, providing quantitative analysis of active compounds.
Antidepressant potential of silymarin
Year: 2023
Region / City: Gainesville, FL, United States
Topic: Antidepressant research, herbal remedies, silymarin, anxiety, depression
Document Type: Commentary
Institution / Organization: University of Florida
Author: Claire E. Manhard, Brandon Lucke-Wold
Target Audience: Researchers, healthcare professionals, pharmacologists
Period of validity: N/A
Date of approval: May 31, 2023
Date of modifications: N/A
Topics: Atherosclerosis ARIC Antidepressant